Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects

Bibliography

• Singh B, Pahuja S, Kapil R, Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics. Acta Pharm 2009;59(1):1-13
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using "Design of Experiments" Part 1: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27-106
   PubMed Web of Science ®Google Scholar
• Dhawan S, Kapil R, Singh B. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J Pharm Pharmacol 2011;63:342-51
   PubMed Web of Science ®Google Scholar
• Doornbos DA, Haan P. Optimization techniques in formulation and processing. In: Swarbrick J, Boylan JC. editors. Encyclopedia of Pharmaceutical Technology. Marcel Dekker; New York; 1995. p. 77-160
   Google Scholar
• Schwartz JB, Connor RE. Optimization techniques in pharmaceutical formulation and processing. In: Banker GS, Rhodes CT. editors. Modern Pharmaceutics. Marcel Dekker; New York; 1996. p. 727-52
   Google Scholar
• Singh B, Mehta G, Kumar R, Design, development and optimization of nimesulide-loaded loiposomal systems for topical application. Curr Drug Deliv 2005;2:143-53
   PubMedGoogle Scholar
• Lewis GA. Optimization methods. In: Swarbrick J, Boylan JC. editors. Encyclopedia of Pharmaceutical Technology. Marcel Dekker; New York; 2002. p. 1922-37
   Google Scholar
• Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 2008;25(4):781-91
   PubMed Web of Science ®Google Scholar
• Huang J, Kaul G, Cai C, Quality by design case study: an integrated multivariate approach to drug product and process development. Int J Pharm 2009;382(1-2):23-32
   PubMed Web of Science ®Google Scholar
• Skrdla PJ, Wang T, Antonucci V, Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols. J Pharm Biomed Anal 2009;50(5):794-6
   PubMed Web of Science ®Google Scholar
• Verma S, Lan Y, Gokhale R, Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm 2009;377(1-2):185-98
   PubMed Web of Science ®Google Scholar
• Cogdill RP, Drennen JK. Risk-based Quality by Design (QbD): A taguchi perspective on the assessment of product quality, and the quantitative linkage of drug product parameters and clinical performance. J Pharm Innov 2008;3:23-39
   Google Scholar
• International Conference on Harmonisation; guidance on Q8(R1) pharmaceutical development; addition of annex; availability. Notice. Fed Regist 2009;74(109):27325-6
   Google Scholar
• Nasr MN. Implementation of quality by design (QbD): status, challenges, and next steps. FDA advisory committee for pharmaceutical science. Available from: http://wwwfdagov/ohrms/dockets/ac/06/slides/2006-4241s1_6ppt [Acessed on 30 December 2010]
   Google Scholar
• Yu LX. Implementation of quality-by-design: OGD initiatives. FDA advisory committee for pharmaceutical science. Available from: http://wwwfdagov/ohrms/dockets/ac/06/slides/2006-4241s1_8ppt [Acessed on 03 January 2011]
   Google Scholar
• ICH Draft consensus guideline: pharmaceutical development annex to Q8. Available from: http://www.ich.org/LOB/media/MEDIA4349.pdf [Acessed on 29 December 2010]
   Google Scholar
• Lionberger RA, Lee SL, Lee L, Quality by design: concepts for ANDAs. AAPS J 2008;10(2):268-76
   PubMed Web of Science ®Google Scholar
• Ivic B, Ibric S, Cvetkovic N, Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G. Chem Pharm Bull (Tokyo) 2010;58(7):947-9
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Muniyappan T, Karatgi P, Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments. Drug Dev Ind Pharm 2009;35(10):1219-29
   PubMed Web of Science ®Google Scholar
• Cahyadi C, Heng PW, Chan LW. Optimization of process parameters for a quasi-continuous tablet coating system using Design of Experiments. AAPS PharmSciTech 2011;12(1):119-31
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma. J Pharm Sci 2011;100(5):1760-72
   PubMed Web of Science ®Google Scholar
• Shamma RN, Basalious EB, Shoukri RA. Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration. Int J Pharm 2011;405(1-2):102-12
   PubMed Web of Science ®Google Scholar
• Barmpalexis P, Kachrimanis K, Georgarakis E. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. Eur J Pharm Biopharm 2011;77(1):122-31
   PubMed Web of Science ®Google Scholar
• Sharma S, Sharma N, Das Gupta G. Optimization of promethazine theoclate fast dissolving tablet using pore forming technology by 3-factor, 3-level response surface-full factorial design. Arch Pharm Res 2010;33(8):1199-207
   PubMed Web of Science ®Google Scholar
• Singh B, Rani A, Babita, et al. Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride. Sci Pharm 2010;78:303-23
   PubMedGoogle Scholar
• Huang J, Goolcharran C, Ghosh K. A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methods. Eur J Pharm Biopharm 2011;78(1):141-50
   PubMed Web of Science ®Google Scholar
• Q8R2: Pharmaceutical Development. ICH Harmonised Tripartite Guideline: International Conference on Harmaonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2009
   Google Scholar
• Murphy JR. Screening designs. In: Chow SC. editor. Encyclopedia of Biopharmaceutical statistics. Marcel Dekker; New York: 2003
   Google Scholar
• Shah M, Chuttani K, Mishra AK, Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. Drug Dev Ind Pharm 2011;37(5):526-37
   PubMed Web of Science ®Google Scholar
• Shirsand SB, Suresh S, Jodhana LS, Formulation design and optimization of fast disintegrating Lorazepam tablets by effervescent method. Indian J Pharm Sci 2010;72(4):431-6
   PubMed Web of Science ®Google Scholar
• Gohel MC, Parikh RK, Nagori SA, Fabrication and evaluation of bi-layer tablet containing conventional paracetamol and modified release diclofenac sodium. Indian J Pharm Sci 2010;72(2):191-6
   PubMed Web of Science ®Google Scholar
• Aboelwafa AA, Basalious EB. Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet. AAPS PharmSciTech 2010;11(3):1026-37
   PubMed Web of Science ®Google Scholar
• Tuntikulwattana S, Mitrevej A, Kerdcharoen T, Development and optimization of micro/nanoporous osmotic pump tablets. AAPS 2010;11(2):924-35
   Google Scholar
• Zhang Y, Geng Y. Preparation of sinomenine hydrochloride delayed-onset sustained-release tablets. Zhongguo Zhong Yao Za Zhi 2010;35(6):703-7
   PubMedGoogle Scholar
• Westerhuis JA, Coenegracht PMJ. Multivariate modelling of the pharmaceutical two step process of wet granulation and tabletting with multiblock partial least squares. Chemometrics 1997;11:372-92
   Google Scholar
• Bolton S. Factorial designs. Pharmaceutical statistics: practical and clinical applications. 3rd edition. Marcel Dekker; New York: 1997
   Google Scholar
• Kollipara S, Bende G, Movva S, Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel. Drug Dev Ind Pharm 2010;36(11):1377-87
   PubMed Web of Science ®Google Scholar
• Singh B, Ahuja N. Response surface optimization of drug delivery systems. In: Jain NK. editor. Progress in controlled and novel drug delivery systems. 1st edition. CBS Publishers; New Delhi; 2004. p. 470-509
   Google Scholar
• Kincl M, Turk S, Vrecer F. Application of experimental design methodology in development and optimization of drug release method. Int J Pharm 2005;291(1-2):39-49
   PubMedGoogle Scholar
• Sousa JJ, Sousa A, Moura MJ, The influence of core materials and film coating on the drug release from coated pellets. Int J Pharm 2002;233(1-2):111-22
   PubMedGoogle Scholar
• Sousa JJ, Sousa A, Podczeck F, Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm 2002;232(1-2):91-106
   PubMed Web of Science ®Google Scholar
• Lundqvist AE, Podczeck F, Newton JM. Compaction of, and drug release from, coated drug pellets mixed with other pellets. Eur J Pharm Biopharm 1998;46(3):369-79
   PubMed Web of Science ®Google Scholar
• Hogan J, Shue PI, Podczeck F, Investigations into the relationship between drug properties, filling, and the release of drugs from hard gelatin capsules using multivariate statistical analysis. Pharm Res 1996;13(6):944-9
   PubMed Web of Science ®Google Scholar
• Vaghani SS, Patel SG, Jivani RR, Design and optimization of a stomach-specific drug delivery system of repaglinide: application of simplex lattice design. 2010; In print
   Google Scholar
• Gohel MC, Parikh RK, Aghara PY, Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate. Curr Drug Deliv 2009;6(5):486-94
   PubMedGoogle Scholar
• Shah PP, Mashru RC, Rane YM, Design and optimization of artemether microparticles for bitter taste masking. Acta Pharm 2008;58(4):379-92
   PubMed Web of Science ®Google Scholar
• Leonardi D, Salomon CJ, Lamas MC, Development of novel formulations for Chagas' disease: optimization of benznidazole chitosan microparticles based on artificial neural networks. Int J Pharm 2009;367(1-2):140-7
   PubMedGoogle Scholar
• Zhang XY, Chen DW, Jin J, Artificial neural network parameters optimization software and its application in the design of sustained release tablets. Yao Xue Xue Bao 2009;44(10):1159-64
   PubMedGoogle Scholar
• Gohel M, Nagori SA. Fabrication and evaluation of captopril modified-release oral formulation. Pharm Dev Technol 2009;14(6):679-86
   PubMed Web of Science ®Google Scholar
• Barmpalexis P, Kanaze FI, Kachrimanis K, Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation. Eur J Pharm Biopharm 2010;74(2):316-23
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Yakou S, Yanagawa F, Evaluation and optimization of preparative variables for controlled-release floatable microspheres prepared by poor solvent addition method. Drug Dev Ind Pharm 2008;34(11):1238-45
   PubMed Web of Science ®Google Scholar
• Lewis GA, Mathieu D, Phan-Tan-Luu R. Pharmaceutical experimental design. In: Singh B, Ahuja N, editors. Book Review on "Pharmaceutical Experimental Design". 1st edition. Marcel Dekker, New York. 2000. Int J Pharm 1999;195:247-8
   Google Scholar
• Myers WR. Response surface methodology. In: Chow SC. editor. Encyclopedia of Biopharmaceutical statistics. Marcel Dekker; New York: 2003
   Google Scholar
• Varshosaz J, Eskandari S, Tabakhian M. Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design. Pharm Dev Technol 2010;15(1):89-96
   PubMed Web of Science ®Google Scholar
• Narkar M, Sher P, Pawar A. Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method. AAPS PharmSciTech 2010;11(1):267-77
   PubMed Web of Science ®Google Scholar
• Pund S, Joshi A, Vasu K, Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. Int J Pharm 2010;388(1-2):64-72
   PubMedGoogle Scholar
• Patel NV, Patel JK, Shah SH. Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. Acta Pharm 2010;60(1):39-54
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Ghaffari S, Khoshayand MR, Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J Liposome Res 2010;20(2):97-104
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT, Fang JY. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm 2010;36(7):751-61
   PubMed Web of Science ®Google Scholar
• Mahmoud EA, Bendas ER, Mohamed MI. Effect of formulation parameters on the preparation of superporous hydrogel self-nanoemulsifying drug delivery system (SNEDDS) of carvedilol. AAPS PharmSciTech 2010;11(1):221-5
   PubMed Web of Science ®Google Scholar
• You X, Wang R, Tang W, Self-microemulsifying drug delivery system of patchoulic alcohol to improve oral bioavailability in rats. Zhongguo Zhong Yao Za Zhi 2010;35(6):694-8
   PubMedGoogle Scholar
• Zhang AY, Fan TY. Optimization of calcium alginate floating microspheres loading aspirin by artificial neural networks and response surface methodology. Beijing Da Xue Xue Bao 2010;42(2):197-201
   PubMedGoogle Scholar
• Asnaashari S, Khoei NS, Zarrintan MH, Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets. Pharm Dev Technol 2011;16(4):400-7
   PubMed Web of Science ®Google Scholar
• Bei D, Marszalek J, Youan BB. Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables. AAPS PharmSciTech 2009;10(3):1032-9
   PubMed Web of Science ®Google Scholar
• Xu H, He L, Nie S, Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release 2009;140(1):61-8
   PubMed Web of Science ®Google Scholar
• Madgulkar A, Bhalekar M, Swami M. In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design. AAPS PharmSciTech 2009;10(3):743-51
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Veiga F, Ribeiro A, Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. Eur J Pharm Biopharm 2009;73(1):25-33
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Tang X, Peng B, Optimization of a floating osmotic pump system of dipyridamole using central composite design-response surface methodology. Yao Xue Xue Bao 2009;44(2):203-7
   PubMedGoogle Scholar
• Giri TK, Sa B. Statistical evaluation of influence of polymers concentration on disintegration time and diazepam release from quick-disintegrating rapid release tablet. Yakugaku Zasshi 2009;129(9):1069-75
   PubMed Web of Science ®Google Scholar
• Madgulkar AR, Bhalekar MR, Padalkar RR. Formulation design and optimization of novel taste masked mouth-dissolving tablets of tramadol having adequate mechanical strength. AAPS PharmSciTech 2009;10(2):574-81
   PubMed Web of Science ®Google Scholar
• Zhu S, Hong M, Liu C, Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm Dev Technol 2009;14(6):642-9
   PubMed Web of Science ®Google Scholar
• Ghareeb MM, Abdulrasool AA, Hussein AA, Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech 2009;10(4):1206-15
   PubMed Web of Science ®Google Scholar
• Sultana S, Bhavna, Iqbal Z, Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm. J Microencapsul 2009;26(5):385-93
   PubMed Web of Science ®Google Scholar
• Rao MR, Borate SG, Thanki KC, Development and in vitro evaluation of floating rosiglitazone maleate microspheres. Drug Dev Ind Pharm 2009;35(7):834-42
   PubMed Web of Science ®Google Scholar
• Madgulkar AR, Bhalekar MR, Kolhe VJ, Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology. Indian J Pharm Sci 2009;71(4):387-94
   PubMed Web of Science ®Google Scholar
• Sharma V, Philip AK, Pathak K. Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin. AAPS PharmSciTech 2008;9(1):87-94
   PubMed Web of Science ®Google Scholar
• Coimbra PA, De Sousa HC, Gil MH. Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul 2008;25(3):170-8
   PubMed Web of Science ®Google Scholar
• Gupta R, Pathak K. Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine. Drug Dev Ind Pharm 2008;34(11):1201-8
   PubMed Web of Science ®Google Scholar
• Prajapati ST, Patel LD, Patel DM. Gastric floating matrix tablets: design and optimization using combination of polymers. Acta Pharm 2008;58(2):221-9
   PubMed Web of Science ®Google Scholar
• Xie H, Gan Y, Ma S, Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network. Drug Dev Ind Pharm 2008;34(4):363-72
   PubMed Web of Science ®Google Scholar
• Zidan AS, Sammour OA, Hammad MA, Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int J Pharm 2007;332(1-2):55-63
   PubMed Web of Science ®Google Scholar
• Shah TJ, Amin AF, Parikh JR, Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech 2007;8(2):Article 29
   Google Scholar
• Rawat M, Saraf S. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS PharmSciTech 2007;8(4):E116
   Google Scholar
• Tomuta I, Leucuta SE. The influence of formulation factors on the kinetic release of metoprolol tartrate from prolong release coated minitablets. Drug Dev Ind Pharm 2007;33(10):1070-7
   PubMed Web of Science ®Google Scholar
• Narendra C, Srinath MS, Babu G. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech 2006;7(2):E34
   Google Scholar
• Yue PF, Yuan HL, Li XY, Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm 2010;387(1-2):139-46
   PubMed Web of Science ®Google Scholar
• Beretzky A, Antal I, Karsai J, Optimatization of pellet preparation is CF-granulator with factorial design. Acta Pharm Hung 2008;78(1):37-43
   PubMedGoogle Scholar
• Wang C, Chen F, Li JZ, Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system. Yakugaku Zasshi 2008;128(5):773-82
   PubMed Web of Science ®Google Scholar
• Agarwal V, Nazzal S, Khan MA. Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid. Pharm Dev Technol 2008;13(4):291-8
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez ML, Barros LB, Palma J, Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm 2007;337(1-2):336-45
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Zahrooni M. Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsul 2007;24(3):253-62
   PubMed Web of Science ®Google Scholar
• Furlanetto S, Maestrelli F, Orlandini S, Optimization of dissolution test precision for a ketoprofen oral extended-release product. J Pharm Biomed Anal 2003;32:159-65
   PubMed Web of Science ®Google Scholar
• Moraes CM, de Matos AP, Grillo R, Screening of formulation variables for the preparation of poly(epsilon-caprolactone) nanocapsules containing the local anesthetic benzocaine. J Nanosci Nanotechnol 2011;11(3):2450-7
   PubMed Web of Science ®Google Scholar
• Mallipeddi R, Saripella KK, Neau SH. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Int J Pharm 2010;385(1-2):53-65
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Mohammadi MY. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J Liposome Res 2010;20(4):286-96
   PubMed Web of Science ®Google Scholar
• Goel H, Vora N, Tiwary AK, Formulation of orodispersible tablets of ondansetron HCl: investigations using glycine-chitosan mixture as superdisintegrant. Yakugaku Zasshi 2009;129(5):513-21
   PubMed Web of Science ®Google Scholar
• Goel H, Vora N, Rana V. A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting. AAPS PharmSciTech 2008;9(3):774-81
   PubMed Web of Science ®Google Scholar
• Jin SJ, Yoo YH, Kim MS, Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design. Arch Pharm Res 2008;31(3):399-405
   PubMed Web of Science ®Google Scholar